Excaliard Pharmaceuticals
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2141 Palomar Airport Rd Ste 300, Carlsba...Phone Number
(760) 431-1850Website
www.excaliard.comRevenue
$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Excaliard Pharmaceuticals
Excaliard Pharmaceuticals is a biotechnology company founded in 2007 that develops and commercializes innovative drugs for treating skin scarring and fibrotic disorders. The company operates in the pharmaceutical manufacturing industry with multiple locations. Excaliard focuses on creating antisense oligonucleotide drugs that target specific proteins involved in the scarring process following wound healing. Their research aims to address unmet medical needs in dermatological conditions related to excessive scarring and fibrosis.Explore more
Popular SearchesEXCALIARD PHARMACEUTICALS IncExcaliard PharmaceuticalsExcaliardExcaliardpharmaceuticalsincMengkaji IndustriSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Excaliard Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Excaliard Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Excaliard Pharmaceuticals had a recent Job posting/layoffs
Check if Excaliard Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Excaliard Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Excaliard Pharmaceuticals has new funding data
Product Launch: Get notified when Excaliard Pharmaceuticals launches new products
Earning: See what the market has to say on Excaliard Pharmaceuticals recently announced quarterly report
Excaliard Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Excaliard Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Excaliard Pharmaceuticals
Compare insights from companies similar to Excaliard Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Excaliard Pharmaceuticals
$5M
11-50
Private
$15.5M
2006
N/A
Company Profile Activity
Activity Insights
Excaliard Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Excaliard Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Excaliard Pharmaceuticals.
Excaliard Pharmaceuticals financials insights
Gather financial insights about Excaliard Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series A
$15.5M
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Excaliard Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Excaliard Pharmaceuticals is a biotechnology company founded in 2007 that develops and commercializes innovative drugs for treating skin scarring and fibrotic disorders. The company operates in the pharmaceutical manufacturing industry with multiple locations. Excaliard focuses on creating antisense oligonucleotide drugs that target specific protei... Read More
